Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer

Abstract Objective It has been demonstrated that IDO1, a target of immune checkpoint inhibition, functions as an oncogene in the majority of human malignancies. IDO1’s function in human pan-cancers hasn’t been thoroughly studied, though. Materials and methods The Kaplan–Meier (K-M) and COX analyses...

Full description

Bibliographic Details
Main Authors: Kaili Lin, Yongfeng Wang, Fangyu Liu, Taifu You, Xiongxiong Liu, Runzhang Liu, Zeyang Li, Chunyu Zhen, Yunxia Zhang, Xingguang Liu, Hui Cai
Format: Article
Language:English
Published: BMC 2024-03-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-024-01766-y
_version_ 1797233738201956352
author Kaili Lin
Yongfeng Wang
Fangyu Liu
Taifu You
Xiongxiong Liu
Runzhang Liu
Zeyang Li
Chunyu Zhen
Yunxia Zhang
Xingguang Liu
Hui Cai
author_facet Kaili Lin
Yongfeng Wang
Fangyu Liu
Taifu You
Xiongxiong Liu
Runzhang Liu
Zeyang Li
Chunyu Zhen
Yunxia Zhang
Xingguang Liu
Hui Cai
author_sort Kaili Lin
collection DOAJ
description Abstract Objective It has been demonstrated that IDO1, a target of immune checkpoint inhibition, functions as an oncogene in the majority of human malignancies. IDO1’s function in human pan-cancers hasn’t been thoroughly studied, though. Materials and methods The Kaplan–Meier (K-M) and COX analyses were applied to the survival analysis. Furthermore, we used Spearman’s correlation analysis to examine the associations between IDO1 and microsatellite instability (MSI), DNA methyltransferases (DNMTs), tumor mutational burden (TMB), the associated genes of mismatch repair (MMR), and immune checkpoint biomarkers. Moreover, immunohistochemical analysis and qRT-PCR were used to evaluate IDO1’s expression in pan-cancer cells. Results The findings of this study reveal that IDO1 has abnormal expression in a number of malignancies and is related to the prognosis for UVM, LGG, KIRP, GBM, LAML, OV, READ, MESO, SARC, SKCM, and HNSC. Furthermore, the aberrant IDO1 expression was connected to the TMB, MSI, MMR, drug sensitivity, immune cells infiltrating, and tumor immune microenvironment across a variety of cancer types. The PCR results showed that in contrast to normal cells, IDO1 was found to be significantly highly expressed in breast cancer cells and hepatocellular carcinoma cells, and significantly lowly expressed in gastric cancer cells. Conclusion The clinical treatment of IDO1 is now better supported by a theoretical basis and guidelines provided by our study.
first_indexed 2024-04-24T16:20:56Z
format Article
id doaj.art-4601ee29489649558ea1996db53105b7
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-04-24T16:20:56Z
publishDate 2024-03-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-4601ee29489649558ea1996db53105b72024-03-31T11:13:42ZengBMCEuropean Journal of Medical Research2047-783X2024-03-0129111910.1186/s40001-024-01766-yComprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancerKaili Lin0Yongfeng Wang1Fangyu Liu2Taifu You3Xiongxiong Liu4Runzhang Liu5Zeyang Li6Chunyu Zhen7Yunxia Zhang8Xingguang Liu9Hui Cai10Lanzhou First People’s HospitalThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityThe First Clinical Medical College of Lanzhou UniversityGeneral Surgery Clinical Medical Center, Gansu Provincial HospitalAbstract Objective It has been demonstrated that IDO1, a target of immune checkpoint inhibition, functions as an oncogene in the majority of human malignancies. IDO1’s function in human pan-cancers hasn’t been thoroughly studied, though. Materials and methods The Kaplan–Meier (K-M) and COX analyses were applied to the survival analysis. Furthermore, we used Spearman’s correlation analysis to examine the associations between IDO1 and microsatellite instability (MSI), DNA methyltransferases (DNMTs), tumor mutational burden (TMB), the associated genes of mismatch repair (MMR), and immune checkpoint biomarkers. Moreover, immunohistochemical analysis and qRT-PCR were used to evaluate IDO1’s expression in pan-cancer cells. Results The findings of this study reveal that IDO1 has abnormal expression in a number of malignancies and is related to the prognosis for UVM, LGG, KIRP, GBM, LAML, OV, READ, MESO, SARC, SKCM, and HNSC. Furthermore, the aberrant IDO1 expression was connected to the TMB, MSI, MMR, drug sensitivity, immune cells infiltrating, and tumor immune microenvironment across a variety of cancer types. The PCR results showed that in contrast to normal cells, IDO1 was found to be significantly highly expressed in breast cancer cells and hepatocellular carcinoma cells, and significantly lowly expressed in gastric cancer cells. Conclusion The clinical treatment of IDO1 is now better supported by a theoretical basis and guidelines provided by our study.https://doi.org/10.1186/s40001-024-01766-yIDO1PrognosisBioinformatics analysisCancers
spellingShingle Kaili Lin
Yongfeng Wang
Fangyu Liu
Taifu You
Xiongxiong Liu
Runzhang Liu
Zeyang Li
Chunyu Zhen
Yunxia Zhang
Xingguang Liu
Hui Cai
Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
European Journal of Medical Research
IDO1
Prognosis
Bioinformatics analysis
Cancers
title Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
title_full Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
title_fullStr Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
title_full_unstemmed Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
title_short Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
title_sort comprehensive analysis of the prognostic value and immunological role of ido1 gene in pan cancer
topic IDO1
Prognosis
Bioinformatics analysis
Cancers
url https://doi.org/10.1186/s40001-024-01766-y
work_keys_str_mv AT kaililin comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT yongfengwang comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT fangyuliu comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT taifuyou comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT xiongxiongliu comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT runzhangliu comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT zeyangli comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT chunyuzhen comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT yunxiazhang comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT xingguangliu comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer
AT huicai comprehensiveanalysisoftheprognosticvalueandimmunologicalroleofido1geneinpancancer